Tracy Rose, MD, MPH (IMAGE)
Caption
“Advanced, metastatic kidney cancer is highly treatable with targeted therapy, immunotherapy or a combination of these newer therapies,” said Tracy Rose, MD, MPH, associate professor of medicine at UNC School of Medicine. “Understanding the science underlying the disease has allowed for the rational development of therapies that have positively affected many patients the past two decades.”
Credit
UNC Lineberger Comprehensive Cancer Center
Usage Restrictions
None
License
Original content